Physician

Christopher Anzalone, D.O.

According to 2025 Medicare claims, Christopher Anzalone, D.O. (NPI: 1346604865) practices cardiology in the Billings, MT market, with the plurality of this provider's patient population coming from Yellowstone, MT. This provider's primary affiliated billing organization is SCL HEALTH MEDICAL GROUP - BILLINGS LLC (NPI: 1508289703; TIN: 464056262) and primary practice location at 59101-7502. Anzalone is affiliated with the Rocky Mountain Accountable Health Network, Inc (ACO ID: A2217), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Anzalone's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,111 traditional Medicare patients, billed 3,999 HCPCS/CPT codes, and received $185,416 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 1,657 prescription claims across 314 beneficiaries totaling $295,740 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 11 claims. Open Payments data shows 4 records totaling $65. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,388 to $295,740. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	601	1,552	$59,981
2023	879	3,178	$140,492
2024	1,111	3,999	$185,416

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	33	69	$3,388
2020	131	470	$20,703
2021	117	469	$34,597
2022	104	302	$23,559
2023	231	1,170	$191,309
2024	314	1,657	$295,740

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	13	$27,407
2021	N/R	11	$22,279
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	574	585	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	250	281	$93
Q9957	Injection, perflutren lipid microspheres, per ml	174	345	$32
93325	Ultrasound of heart with color-depicted blood flow, rate and valve function	136	138	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	327	339	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	117	6,480	$122,189
Jardiance	Empagliflozin	89	5,042	$92,600
Entresto	Sacubitril/Valsartan	27	1,673	$36,816
Metoprolol Succinate	Metoprolol Succinate	274	21,009	$3,405
Ranolazine Er	Ranolazine	35	1,730	$2,152

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$65	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Anzalone, D.O.?

Tedicare shows public-source Medicare data for Christopher Anzalone, D.O. (NPI 1346604865), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Anzalone, D.O. have ACO affiliation data?

Christopher Anzalone, D.O. is shown with ACO affiliation data for Rocky Mountain Accountable Health Network, Inc (MSSP, ACO ID A2217), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Christopher Anzalone, D.O.?

Christopher Anzalone, D.O. is linked to SCL HEALTH MEDICAL GROUP - BILLINGS LLC (billing NPI 1508289703) in the available physician profile data.

Does Christopher Anzalone, D.O. have Open Payments data?

Christopher Anzalone, D.O. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.